Advertisement
A controlled trial of rivaroxaban after transcatheter aortic-valve replacement (GALILEO)
13 Dec 2019
The GALILEO trial was a randomized, open-label, event-driven, international, multicentre trial comparing two different preventive strategies for thromboembolic complications in patients who underwent successful TAVI and had not established indication for oral anticoagulation.
Reviewer
